Response to letter to the editor by Lars Andersson.
The Medical Products Agency, Uppsala, Sweden.
I
I
Persson
D003627:Data Interpretation, Statistical; D003922:Diabetes Mellitus, Type 1; D006801:Humans; D007252:Influenza Vaccines / Q000009:adverse effects*; D012042:Registries; D014611:Vaccination / Q000009:adverse effects*
D007252:Influenza Vaccines; C556153:pandemrix